Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adial Pharmaceuticals (ADIL) Amortizatization of Intangibles (2022 - 2024)

Adial Pharmaceuticals' Amortizatization of Intangibles history spans 3 years, with the latest figure at $141.0 for Q4 2024.

  • For Q4 2024, Amortizatization of Intangibles changed 0.0% year-over-year to $141.0; the TTM value through Dec 2024 reached $565.0, changed 0.18%, while the annual FY2025 figure was $565.0, 0.0% changed from the prior year.
  • Amortizatization of Intangibles for Q4 2024 was $141.0 at Adial Pharmaceuticals, down from $142.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $12910.0 in Q2 2022 and bottomed at -$25126.0 in Q3 2022.
  • The 3-year median for Amortizatization of Intangibles is $141.0 (2022), against an average of $141.08.
  • The largest YoY upside for Amortizatization of Intangibles was 100.56% in 2023 against a maximum downside of 98.91% in 2023.
  • A 3-year view of Amortizatization of Intangibles shows it stood at $141.0 in 2022, then changed by 0.0% to $141.0 in 2023, then changed by 0.0% to $141.0 in 2024.
  • Per Business Quant, the three most recent readings for ADIL's Amortizatization of Intangibles are $141.0 (Q4 2024), $142.0 (Q3 2024), and $141.0 (Q2 2024).